Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Bonefish who wrote (1218361)	4/8/2020 6:35:08 PM
From: SeachRE	Read Replies (1) \| Respond to of 1583492

States are being showered with CQ pills by drug makers, all for FREE. But the patients taking them may be angry later with permanent eye, kidney or heart damage. There are some serious side-effects occasionally even in stable, arthritic patients. So, one should expect more problems with ICU cases, and they are finding them. BTW, In Shanghai, docs were not overly impressed with CQ for CV19 in the sickest patients. Although, drug may be better in the moderate but needs confirmation by studies. Vide reports that lupus patients on CQ are not getting much CV19. It's anecdotal but interesting.